- $12.60bn
- $15.94bn
- $5.94bn
Encompass Health Corp reports results for the quarter ended in December - Earnings Summary
Brief: Encompass Health Q4 Adjusted EPS USD 0.95 Vs. IBES Estimate USD 0.82
Encompass Health Corp expected to post earnings of 82 cents a share - Earnings Preview
Brief: Encompass Health Appoints Ted Christie To Its Board Of Directors
Brief: Encompass Health Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Encompass Health Corp reports results for the quarter ended in September - Earnings Summary
Brief: Encompass Health Q3 adjusted EPS USD 0.86
Encompass Health Corp expected to post earnings of 77 cents a share - Earnings Preview
Encompass Health Corp reports results for the quarter ended in June - Earnings Summary
Brief: Encompass Health Q2 Adjusted EPS USD 0.95 Vs. IBES Estimate USD 0.75
Encompass Health Corp expected to post earnings of 75 cents a share - Earnings Preview
Arex Capital pushes Enhabit to consider company sale - letter
U.S. RESEARCH ROUNDUP-Chegg, Humana, Paratek Pharmaceuticals
U.S. RESEARCH ROUNDUP-Avalonbay Communities, B&G Foods, Essex Property Trust
Encompass Health Corp reports results for the quarter ended in March - Earnings Summary
Brief: Encompass Health Reports Results For First Quarter 2023
Brief: Encompass Health Q1 operating revenue USD 1,160.4 million
Encompass Health Corp expected to post earnings of 70 cents a share - Earnings Preview
Brief: Encompass Health Corp - Co Continues To Expect FY 2023 Net Operating Revenue Of $4,680 Million To $4,760 Million